CRS Sponsors Make It Happen

3M Drug Delivery Systems

3M Drug Delivery Systems is a global leader in transdermal and inhalation drug delivery development and components. Between drug discovery and commercialization, we offer innovative and proven technology, product development services, global regulatory expertise, commercial manufacturing, and a broad range of customizable system components. Our expertise increases your opportunity for success.

Allergan

Founded in 1950, Allergan, Inc., with headquarters in Irvine, California, is a multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential—to see more clearly, move more freely, express themselves more fully. The company employs approximately 8,300 people worldwide and operates state-of-the-art R&D facilities and world-class manufacturing plants. In addition to its discovery-to-development research organization, Allergan has global marketing and sales capabilities with a presence in more than 100 countries.

www.astrazeneca.com

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009.

www.banpharm.com

Banner is a specialty pharma company in gelatin-based products committed to researching, developing, and producing unique oral dosage forms for the healthcare industry. Innovative drug delivery systems are Versatrol™ controlled delivery system, EnteriCare® enteric softgels, Chewels® chewable softgels, LiquiSoft™ liquid-filled softgels, Soflet® gelcaps, and Solvatrol™ solubility systems.

www.pharma-solutions.basf.com

BASF facilitates the success of Pharmaceutical companies with a range of innovative excipients, which are supported by experienced technical staff with industry-specific formulation expertise, to improve the functionality of pharmaceutical products. BASF also supplies active ingredients and provides exclusive custom synthesis services.

Celanese EVA Performance Polymers

Celanese EVA Performance Polymers manufactures and markets VitalDose™ excipients for use in controlled-release pharmaceuticals and medical devices. Celanese EVA Performance Polymers combines the unique properties of EVA polymers with high-touch service, in-depth technical expertise, and comprehensive regulatory knowledge. VitalDose polymers can be custom-designed to meet your exacting delivery needs.

Coating Place Inc.

Coating Place, Inc. is a drug delivery development and manufacturing company specializing in Wurster fluid bed microencapsulation. We provide formulation development, technology transfer, scale-up and commercial manufacturing. CPI processes solvent and aqueous formulations. Services include capsule filling, pan coating, extrusion spheronisation and roller compaction. We are DEA and FDA registered.

www.colorcon.com

Colorcon is a world leader in the development, supply, and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our value-added services, which support all phases of solid oral dose design and development.

Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: medical devices, pharmaceuticals and medical supplies. With 2009 revenue of $10.7 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www. covidien.com to learn more about our business

Dissolution Technologies

Dissolution Technologies is a peer-reviewed and indexed quarterly journal reporting current information and scientific articles on dissolution testing and related topics. It provides an international forum for an open exchange of information. Educational items related to dissolution topics are available on the website, www.dissolutiontech.com, as are all back and current issues.

Diurnal

Diurnal is an innovative pharmaceutical company that creates high-value therapeutics using advanced proprietary formulations and novel physiological treatment regimes of approved drugs for use in the endocrine area. Diurnal’s lead product—Chronocort®— for the treatment of adrenal insufficiency has just completed Phase 1 clinical trials and is expected to be approved in 2014

Drug Delivery Technology

Drug Delivery Technology publishes scientific articles, special features, and market news covering the science and business of drug delivery, formulation development, product lifecycle management, technology assessment, product development, contracting, and licensing. Specialty Pharma is a self-contained featured section inside Drug Delivery Technology addressing the business strategies behind portfolio optimization, pipeline management, and partnering with contract service providers throughout the drug development process.

DSM Biomedical

Within the Trancerta™ Drug Delivery portfolio, DSM Biomedical offers bioresorbable materials for the controlled release of small molecules and biologics. Focusing on ophthalmic, (cardio)vascular, orthopedic and pain management therapeutic areas, we partner with biopharmaceutical and medical device companies for the joint development of next generation products based on superior delivery science.

Elan Drug Technologies

Elan Drug Technologies, the world’s leading drug delivery business, develops and manufactures innovative pharmaceuticals using our extensive experience and proprietary drug technologies in partnership with pharmaceutical companies. With a 40-year proven track record, we offer a suite of technology-driven solutions to develop innovative and clinically meaningful solutions for our clients

Elsevier

As the world’s leading publisher of science and health information, Elsevier serves more than 30 million scientists, students, and health and information professionals worldwide. We are proud to play an essential role in the global science and health communities and to contribute to the advancement of these critical fields. By delivering world-class information and innovative tools to researchers, students, educators, and practitioners worldwide, we help them increase their productivity and effectiveness. We continuously make substantial investments that serve the needs of the global science and health communities.

Encap Drug Delivery

Encap is a global contract manufacturing and development organisation and the world’s number one company for liquid and semi-solid capsule products. We offer expertise in all aspects of the development and manufacture of pharmaceuticals for oral drug delivery.

Eurand

Eurand is a global specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had six partnered and proprietary products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and collaboration partners. Eurand has a strong track record of developing products using its innovative drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has one of the broadest, well-validated ranges of pharmaceutical technology platforms: customized drug release, bioavailability enhancement, and taste masking/orally disintegrating tablets (ODTs).

F. Hoffmann-La Roche Ltd.

Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism, and CNS. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan.

Givaudan

With over 200 years of experience, Givaudan is recognized as the world leader in flavour. Creating the world’s best-tasting flavours for the savoury, confectionery, dairy and beverages markets, we take pride in our consistently high-quality products, on-time delivery, creativity and skill. Our tailored approach begins with consumer research and integrates all disciplines from new ingredient development to flavour creation, to delivery. We know that flavour creation depends on understanding people and the times they live in. It is, in most ways, not just a business but an art.

Intervet

We are focused on the research, development, manufacturing and marketing of animal health products. Building on a wide base of innovative, high-quality veterinary products, Intervet and Schering-Plough combined businesses represent one of the world’s leading companies in the field of animal health and is the world market leader in the production of animal health vaccines.

LTS Lohmann Therapie-Systeme

LTS is a leading provider of tailor-made therapeutic transdermal and oral thin-film products and services. We offer a unique one-stop shop, from formulation development and scale-up to commercial manufacturing, including clinical services for your NCE, line extension, or generic strategy. Our FDA- and EMEA-registered production facilities are located in the United States and Germany.

Merial

Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,700 people and operates in more than 150 countries worldwide. Its 2009 sales were $2.6 billion. Merial is the Animal Health subsidiary of sanofi-aventis.

Microtek Laboratories, Inc

Microtek leads the way in microencapsulation technologies. As a privately-held company founded in 1985, we specialize in custom microencapsulation and product development services. From product conception, to process development, to full production, we strive to leverage our more than 100 years combined microencapsulation experience for the benefit of our clients.

Molecular Pharmaceutics

Molecular Pharmaceutics publishes high-quality research advancing the understanding of pharmaceutics at the molecular level, while providing a forum for research among the fields of physical and pharmaceutical chemistry, biochemistry, molecular and cell biology, and polymer and materials science focused on drug delivery. The journal publishes periodic “Featured Topic” issues on areas of key interest. To avoid ambiguities please use abbreviation Mol. Pharmaceutics when citing articles published in the journal. pubs.acs.org/molecularpharmaceutics

Molecular Profiles

Molecular Profiles is a world-leading analytical research company servicing pharmaceutical and biomedical sectors. Combining state-of-the-art technology with our expertise, we go beyond conventional analysis to provide in-depth understanding of the chemical and physical properties of drug delivery systems. Our service is applied throughout R&D, lifecycle management and patent disputes.

Mylan Technologies

Mylan Technologies Inc. (MTI) is the global partner of choice for transdermal pharmaceuticals. Industry-leading science and technology earned MTI four of the first six generic transdermal approvals from the FDA. MTI maintains advanced R&D and manufacturing capabilities and is the largest manufacturer of transdermal generics in the United States.

The Nagai Foundation

The Nagai Foundation Tokyo was founded in 1986 in commemoration of Prof. Tsuneji Nagai receiving the 1986 Hoest-Madsen Medal from FIP as the first for Japanese. Then the Foundation was officially approved as government-licensed in 1994 for the purpose of promoting international exchange in pharmacy and pharmaceutical sciences.

NOF Corporation

NOF manufactures and supplies outstanding quality excipients for drug delivery systems and pharmaceutical formulation, such as activated PEGs, lipids (phospholipids, PEGylated lipids, and cationic lipids etc.), high purity Polysorbate 80 and solubilizing novel excipients etc. NOF offers those excipients from reagent from GMP bulk product. NOF produces and supplies activated PEGs and lipids under state-of-the-art cGMP facilities. With headquarters in Tokyo, Japan (+81-3-5424-6741) and offices in New York (toll free: 1-866-NOF-0001; 914-681-9790), California (1-866-NOF-0001) and Belgium (+32-14-259830), we look forward to meeting you at our CRS booth #303 to provide more detailed information.

Northern Lipids

Northern Lipids is a contract manufacturing organization that also specializes in offering services for preclinical and clinical development of lipid-based pharmaceutical formulations such as liposomes, emulsions and micelles. We provide LIPEX™ brand of extruders, customized formulation development, scale up and analytical services from R&D through to commercialization

ONdrugDELIVERY

ONdrugDelivery is a highly regarded series of sponsored themed drug delivery publications. Each issue focuses tightly on one topic within the field of drug delivery. With a rapidly growing global readership already in excess of 30,000 and with contributions and support from many of the leading companies—large and small—in the worldwide drug delivery business, reading ONdrugDelivery is a must. Subscription to the print and pdf versions is free at: www.ondrugdelivery.com.

Pfizer

At Pfizer, we apply science and our global resources to improve health and wellbeing at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s bestknown consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

Pfizer Animal Health

Pfizer Animal Health is a world leader in the discovery, development and manufacture of vaccines and medicines for companion animals and livestock species. We work to assure a safe, sustainable food supply from healthy cattle, swine, poultry, and fish and strive to help dogs, cats, and horses live healthy longer. www.pfizerah.com

Pharmaceutical Manufacturing and Packing Sourcer (PMPS)

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of the pharmaceutical manufacturing and packaging sector. Published quarterly, the journal is a platform of communication and information-sharing, identifying new trends and marketing opportunities as well as highlighting the latest innovations. PMPS focuses on the interests of those in the pharmaceutical, biotech, nutritional and medical device industries who actively seek to improve efficiency in an increasingly competitive market. Distribution is 10,500, targeted directly at the industry’s strategic decision-makers and their contract partners, primarily in Europe, but increasingly to North America and the rest of the world.

Pharmaceutical Technology

Pharmaceutical Technology (PharmTech.com) is the only peerreviewed publication serving the largest requested circulation of 38,600 BPA-audited subscribers. With 30-plus years in the bio/pharmaceutical community, we deliver in-depth analysis and reporting on the formulation and manufacture of APIs, excipients, and raw materials throughout the product life cycle, including supply-chain tools and standards.

PolyMedex Discovery Group-Delivery Science

PolyMedex Discovery Group-Delivery Science specializes in melt extrusion blending and forming of highly regulated materials, including implantable and bioresorbable drug delivery polymers used in combination devices and pharmaceuticals. We offer formulation, feasibility, process development, scale up and manufacturing services in an ISO Class 8 cGMP clean room environment.

Shire

Shire is a specialty biopharmaceutical company that focuses on meeting the specialist physician’s needs. Through in-licensing, acquisition, and in-house research efforts, Shire has developed a portfolio of products for attention deficit and hyperactivity disorder, human genetic therapies, and gastrointestinal diseases that can be marketed by a small sales force.

Valeo Partners

Valeo Partners, headquartered in Washington, DC, is a leading consultancy providing advisory services to clients in North America, Europe, Asia, the Middle East, and Latin America. With decades of consulting and industry experience, our partners have helped clients to meet and exceed their most critical objectives by providing them with business development and licensing services, primary market research, business planning and market strategy, and mergers & acquisitions advisory. Valeo Partners is currently representing clients with innovative technology offerings, product opportunities, and company divestitures. For more information please contact Debra Bingham, Partner, Valeo Partners, dbingham@ valeopartners.com.